FTLP1

Across TCGA pan-cancer cohorts, FTLP1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated FTLP1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher FTLP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FTLP1 expression acts as an unfavorable survival marker, although some lineages such as CESC and COAD show a favorable association.

MESO, LGG, and LIHC are the cancer types where FTLP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	IV	0.137	0.669	<.001	38	view →
LGG	DFS	Quartile	All	0.742	0.852	<.001	28	view →
LIHC	OS	Quartile	All	0.689	0.826	.002	28	view →
STAD	OS	Quartile	III,IV	0.426	0.716	.006	27	view →
CESC	OS	Tertile	II,III,IV	0.777	0.455	.014	24	view →
COAD	DFS	Quartile	All	0.806	0.652	.001	23	view →
OV	OS	Median	IV	0.741	0.496	.004	14	view →
LUSC	DFS	Tertile	II,III,IV	0.329	0.667	.006	14	view →
KIRP	OS	Quartile	All	0.988	0.906	.023	11	view →
CHOL	OS	Tertile	All	0.165	0.737	.015	9	view →
THCA	DFS	Quartile	All	0.988	0.929	.009	8	view →
DLBC	DFS	Median	All	0.919	0.402	.016	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

FTLP1–MESO (OS)

Open the MESO breakdown →